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Objective: Somatic symptoms capture attention, demand interpretation, and promote health 
behaviors. Symptom appraisal is particularly impactful within uncertain health contexts such as 
cancer survivorship. Yet, little is known about how individuals make sense of somatic symptoms 
within uncertain health contexts, nor how this process guides health behaviors.  
Design: 25 adolescent and young adult survivors of childhood cancer completed semi-structured 
interviews regarding how they appraise and respond to changing somatic sensations within the 
uncertain context of survivorship.  
Main Outcome Measures: Interviews were transcribed verbatim and subjected to a hybrid 
deductive-inductive thematic analysis, guided by the Cancer Threat Interpretation model.  
Results: Theme 1 (‘symptoms as signals of bodily threat’) captured that participants commonly 
interpret everyday sensations as indicating cancer recurrence or new illness. Theme 2 (‘playing 
detective with bodily signals’) captured the cognitive and behavioral strategies that participants 
described using to determine whether somatic sensations indicated a health threat. These two 
themes are qualified by the recognition that post-cancer symptoms are wily and influenced by 
psychological factors such as anxiety (Theme 3: ‘living with symptom-related uncertainty’).  
Conclusions: These data highlight the need for novel symptom management approaches that 








 Somatic symptoms are among the most distressing aspects of illness, the most common 
reasons for seeking healthcare, and the most feared parts of treatment. In short, somatic symptoms 
are central to our experience of health and illness. Somatic symptom appraisal is particularly 
important in the context of an ambiguous and uncertain health threat, where symptoms capture 
attention and provide information about the state of health, thereby driving health-related and 
healthcare-initiating behaviors. Yet, symptoms do not provide a direct read-out of the state of body 
tissues. From an evolutionary perspective, somatic symptoms such as pain, itch, nausea, and 
breathlessness act as conscious signals to protect us from actual or potential bodily threat, thus 
promoting protective behaviors even in the absence of underlying pathology (Eccleston, 2016; 
Wall, 1979). In the context of a possible or probable health threat (e.g., new or recurrent illness), 
it can be adaptive to be vigilant for new and changing somatic sensations and to appraise these 
sensations as threatening (e.g., as symptomatic of illness). However, these attentional and 
interpretational biases (also known as cognitive biases) may distort the salience and nature of 
somatic sensation, increasing the risk of an inappropriate behavioral response (e.g., under- or over-
utilization of healthcare). Drawing from research particularly in post-traumatic stress disorder 
(PTSD) (Conoscenti et al., 2009; Forbes et al., 2019), a prolonged state of heightened vigilance 
and perceived threat may also decrease health and wellbeing by promototing maladaptive coping 
and by increasing stress, anxiety, and negative affect over time. The longer-term deleterious 
consequences of symptom vigilance are particularly applicable in the context of a prolonged health 
threat, for example the possibility of disease recurrence over months or years.  
 Cancer survivorship is one such uncertain health context, entailing varied and time-
dependent risk of disease recurrence and treatment sequelae. This uncertain context is particularly 
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pertinent for survivors of childhood cancer, who face a lifetime of health- and symptom-related 
uncertainty (Oeffinger & Robison, 2007). Indeed, 5- and 10-year survival rates for childhood 
cancers have doubled over the last 40 years, with 80% of children now surviving their disease 
(Ward et al., 2014). Today, there are over 400,000 survivors of childhood cancer in the United 
States alone. Yet, childhood cancer survivors will experience an average of 17 chronic health 
conditions by the age of 50; almost twice as many as their healthy peers. Most face a lifetime of 
risk for physical and psychological health challenges, including cancer recurrence, leading to 
decades of healthcare use (Hudson et al., 2003). In addition, childhood cancer survivors face both 
age-typical bodily changes (e.g., physical growth, hormonal maturation) alongside elevated risk 
for frailty and accelerated aging (Henderson et al., 2014), both of which cause profound and 
complex changes in somatic sensation and bodily state. Survivors of childhood cancer therefore 
are a clinical population with both significant symptom-relevant healthcare needs and from whom 
we can learn a great deal about how symptom appraisal influences health and wellbeing within an 
uncertain health context.  
 To date, a small number of quantitative studies indicate that somatic symptoms, 
particularly pain and fatigue, are prevalent and burdensome in adult survivors of childhood cancer 
(Huang et al., 2013; Lu et al., 2011; Miser et al., 1987). These studies also reveal that symptom 
burden is associated with elevated fear of cancer recurrence (Kelada et al., 2019), a primary and 
impactful psychosocial issue in this population. Yet, quantitative studies do not yet indicate the 
mechanisms through which symptoms and fear of recurrence interact, nor how this interaction 
influences health outcomes. We know almost nothing about how childhood cancer survivors attend 
to, interpret, and respond to somatic sensations within the uncertain threat of disease recurrence 
and new illness. Qualitative methods offer a valuable tool to guide theory advancement and 
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hypothesis generation in a relatively new health research field (Braun & Clarke, 2014, 2019b). 
Gaining idiographic rather than nomothetic accounts of the triggers, mechanisms, and 
consequences of symptom appraisal through the lens of the young cancer survivors’ perception of 
their unique health vulnerabilities will be essential to developing appropriate symptom perception 
measures and targeted psychosocial interventions. 
 The majority of extant qualitative research in cancer populations is inductive in nature. For 
example, research using semi-structured interview schedules commonly asks patients to describe 
their general experiences of cancer diagnosis, treatment, or survivorship, with the intent to assess 
shared needs. Yet, there has been substantial theoretical development in psycho-oncology over the 
last 10 years, particularly within the study of fear of cancer recurrence (Sharpe et al., 2017). These 
advancements offer frameworks and models that can aid a complementary, more deductive 
approach. Hybrid deductive-inductive approaches are particularly well suited to situate analyses 
within established theoretical frameworks while still gaining novel insights from the resultant data 
(Fereday & Muir-Cochrane, 2006). Particularly relevant for understanding symptom appraisal in 
the context of cancer survival is the Cancer Threat Interpretation (CTI) theoretical model 
(Heathcote & Eccleston, 2017). The CTI model offers a cognitive-affective account of pain 
appraisal within the uncertain threat of cancer recurrence. It pinpoints cognitive (attentional 
vigilance, threat interpretation, worry) and affective (fear) factors that can influence post-cancer 
pain and provides a potentially fruitful coding framework for qualitative data. Although initially 
conceptualized for understanding pain perception, the CTI model can be applied to understanding 
symptom perception more broadly within the context of both cancer- and health-related 
uncertainty (Heathcote et al., 2018).  
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 The primary objective of this study was to combine the CTI model (Heathcote & Eccleston, 
2017) with a flexible qualitative method (reflexive thematic analysis; Braun & Clarke, 2019a) to 
gain novel and hypothesis-generating insights into the way that survivors of childhood cancer 
perceive and respond to somatic sensations while living with health-related uncertainty. Of note, 
we have previously recognized the value of using the term ‘sensation perception’ rather than 
‘symptom perception’ in research, to distinguish the felt experience from the attribution 
(Heathcote, 2019). Here, we flexibly use both terms to reflect that the term ‘symptoms’ is in 
common language use by both individuals with cancer and those who treat them, thus aligning our 
overarching goal for this qualitative work to be patient- and person-centered.  
MATERIALS & METHODS 
Study Design 
This paper analyzes qualitative data generated through in-depth semi-structured interviews 
of adolescent and young adult survivors of childhood cancer (hereafter referred to as ‘childhood 
cancer survivors’). Interviews focused on the topic of symptom and bodily perception within the 
context of cancer survival. The research question for this paper was as follows: how do childhood 
cancer survivors make sense of and respond to changes in somatic sensations during 
survivorship? Our overall approach is situated within a ‘Big Q’ qualitative framework (Braun & 
Clarke, 2013), focusing on a small clinical sample to generate deep, rich insights into individual 
experiences. This approach acknowledges the researchers’ expertise and motivating theoretical 
frameworks as a valuable part of analytic knowledge production. This approach is set in contrast 
to a ‘small q’ orientation where coding concerns (e.g., reliability, avoiding bias, generalizability) 
stem from a ‘scientific’ positivist-empiricist quantitative orientation. Thus, our approach is 
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purposefully hypothesis-generating and theory-expanding rather than hypothesis- or theory-
confirming. 
Participants  
Participants were recruited from the Bass Center for Childhood Cancer and Blood 
Diseases. Participants aged 15 – 25 years were eligible to participate if they 1) were previously 
diagnosed with any cancer and 2) had finished curative cancer treatment more than one year 
previously. Participants were not eligible to participate if they 1) were unable to read and write in 
English or 2) had significant cognitive impairment. We purposefully over-sampled participants 
with a history of sarcoma and leukemia due to data indicating higher symptom burden in these 
populations [e.g., pain and fatigue; (Lu et al., 2011; Meeske et al., 2005; Mulrooney et al., 2008)]. 
We contacted 46 childhood cancer survivors; 25 agreed to participate (see Table 1). This sample 
size is consistent with best practices for thematic analysis (Braun & Clarke, 2013). Reasons for 
nonparticipation were: lack of response to contact (n = 16), not appearing for the interview (n = 
2), declining to participate (n = 1), or not consenting to audio recording (n = 1). The study protocol 
was approved by the Stanford Medicine Institutional Review Board. 
Procedure 
 Participants took part in individual semi-structured interviews with one or two members of 
the research team (NL and/or LCH). Interview schedules (see supplemental materials) were 
developed by LCH and NL and revised with feedback from AJ. Prior to each interview, informed 
consent was obtained from participants aged 18 or older; informed assent and parental consent was 
obtained from participants aged 17 or younger. Interviews were performed either in person in a 
private meeting room (n=12) or via video call (n=13). Video calls are commonly used in qualitative 
research and provide a viable alternative where in-person methods are not possible (e.g., where 
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patients live far from the clinic) (Iacono et al., 2016). Interviews ranged from 23 to 62 minutes 
(Mdn = 46 minutes), were audio-recorded on two digital devices, and transcribed verbatim.  The 
data that support the findings of this study are available from the corresponding author, LCH, upon 
reasonable request. 
Analysis 
Analysis followed Braun and Clarke’s reflexive thematic analysis method (Braun & 
Clarke, 2006, 2013, 2019a). This qualitative analysis method emphasizes flexibility in 
identification and interpretation of patterns within the data. Our analysis focused on both semantic 
and latent features of the data, considering both what the participants said (i.e., content and 
meaning) and how they said it (i.e., language use). We used a hybrid deductive-inductive analytic 
approach (see also Fereday & Muir-Cochrane, 2006). Specifically, we first deductively generated 
codes from the Cancer Threat Interpretation (CTI) theoretical model (see Figure 1), including 
codes for ‘threat interpretations’, ‘biased attending’, and ‘fear and worry’. Additional codes and 
resultant themes were inductively developed from the data content.  
Following the six steps outlined by Braun and Clarke (Braun & Clarke, 2013), the primary 
coder (NL) first familiarized herself with the data through reading and re-reading transcripts while 
recursively coding the data, using NVivo version 12 (NVivo Qualitative Data Analysis Software, 
1999). Codes were then clustered together into candidate themes to give some indication of their 
prevalence and test their value in giving an overall account of the data. Five candidate themes were 
identified which were then collapsed into three themes to avoid considerable theoretical overlap. 
Coding and theme development were supervised by iterative feedback from LCH (author of the 
CTI model) and AJ (a researcher with over 14 years of experience in thematic and other qualitative 
analyses). In line with a ‘Big Q’ approach, collaborative theme development was used to develop 
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a richer more nuanced reading of the data rather than to seek a consensus on meaning. Themes 
were developed to represent patterns of shared meaning underpinned or united by a core concept, 
rather than domain summaries. Braun & Clarke’s criteria for demonstrating the quality of thematic 
analysis were met (Braun & Clarke, 2013). This included the following: 1) detailed transcriptions 
were checked against audio recordings for accuracy, 2) equal attention was given to each data item 
in the coding process, 3) a balance between data (i.e., quotations) and analytic narrative, 4) most 
participants were represented with one quotation; no participants were represented with more than 
three quotations, and 5) the researcher was positioned as active in the research process.  
RESULTS  
We generated three salient themes related to participants’ appraisals of and responses to 
somatic sensations in the context of living with health-related uncertainty. Excerpts of transcripts 
are provided below as examples of each theme and were selected to illustrate both the central 
components of each theme and the breadth and diversity of perspectives. 
Theme 1: Symptoms as signals of bodily threat 
The first theme captures that somatic sensations during survivorship are often appraised as 
signals of bodily threat. Pain was commonly mentioned as a particularly salient signal of threat, 
especially if it mirrored pain experienced at initial diagnosis or in the previous tumor site.  
Like pain was just like something – especially in like a similar area – I was just super paranoid 
and I would actually not be able to focus on my school work at all. Like I would just like keep 
thinking about it like, ‘oh my gosh am I okay? What do I do?’ – P10, Ewing Sarcoma 
Besides pain, participants described interpreting a range of different somatic sensations as 
indicating bodily threat, including “fatigue” (P14), “tingling” (P20), “nausea” (P16), 
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“lightheadedness” (P25), and being “on the verge of passing out” (P2), as well as more tangible 
changes in bodily state such as “fevers” (P11), going visibly “pale” (P17), and “lumps” (P22).  
Most commonly, the perceived ‘threat’ focused around the cancer returning. 
I have a headache! Does that mean my tumor’s back or does that just mean I have a headache? 
– P4, Brain Tumor 
Some participants described that while they would not worry about a single symptom, they would 
be concerned about a “package” of symptoms. 
If I had like a headache, I wouldn’t particularly attribute that to like having like, being diagnosed 
with cancer again. […] If there’s a huge, severe package of like symptoms or like of problems 
that I was suffering from, then I would maybe […]  go to a doctor. – P21, Burkitt’s Cell Leukemia 
For several particiapants, the fact that the initial symptoms were ignored for so long elevated the 
felt need to interpret future sensations as threatening. In other words, they applied a ‘better-safe-
than-sorry’ strategy to interpreting and responding to post-cancer symptoms. 
Because like one big mistake we made, right, was like at the time of diagnosis we didn't like 
take the pain seriously as we should have the first time and we kinda let it sit and wait. So 
yeah, I'm a lot more cautious about like kind of checking these things out as soon as they arise. 
– P23, Osteosarcoma 
Yet, for others, the lack of symptoms at diagnosis led to the appraisal of sensations as threatening 
during survivorship.  
For me the lack of symptoms that I had initially is terrifying. Cause I can have anything going 
on in my body and I would have no idea. If I feel pain or if something doesn’t feel right [long 
pause], sometimes I overanalyze that. – P9, Wilms’ Tumor 
 11 
The diversity in these perspectives speaks to the question of how symptom experiences during and 
after cancer treatment influence and are influenced by the mindsets that young people hold about 
their bodies. Particularly, whether they view their body as something that can be ‘trusted’ to 
provide accurate information about the state of body tissues, or as a saboteur that is secretly 
working against them and silently spreading or not mitigating disease (Zion et al., 2019).   
Beyond cancer recurrence, participants also described interpreting sensations as indicating 
other potential health threats. This commonly included fears of late effects from their treatment. 
I’m not afraid of cancer, I’m afraid more like of bone death […]. Sometimes like, your shoulder 
hurts or like your knee hurts and you just associate it with like bone death cause that’s common 
between people who get a transplant. – P11, Acute Myeloid Leukemia (AML) 
Other participants talked about symptoms as signals of poor health more generally, speaking to 
awareness of risk for long-term chronic treatment sequalae in this population. 
I do go to the side of worrying [about sensations], but not cancer […]. I think of it being related 
to the past, which I did have cancer but not necessarily that it’s the cancer coming back. It’s 
more like the side-effects of the chemo or me being susceptible to more things. – P14, AML 
Regardless of whether sensations were interpreted as cancer, late effects of treatment, or poor 
health more generally, there was variation in how immediate this threat seemed to participants. To 
some, the first thought was a fleeting ‘what if it’s cancer?’ that was quickly dismissed. 
[With pain] it just kinda quickly flashes to like {snaps}, ‘what if it's cancer?’. But like, I don’t 
really dwell on it for too long. – P20, Acute Lymphoblastic Leukemia (ALL) 
 12 
For other participants, threat interpretations were described as ‘moments’ in time. While the initial 
interpretation was more benign (e.g., a result of better eating and exercise), the threat interpretation 
would later emerge as a ‘what if’, that could then cause sudden alarm.  
Every now and then maybe I would have a moment of like, ‘oh my gosh I am feeling tired 
again, what if it’s the cancer?’. Or like I think I randomly like, had lost some weight. I think it 
had more to do with eating better and moving more and not being so tired all the time that I 
could like resume normal exercise – but I think I was like ‘wait a second I remember, 
lymphomas, one of the potential indicators you have it is weight loss’. So I was like, ‘holy cow 
like what if I’m suddenly losing weight cause the cancer’s actually back?’ So, every now and 
then I will have sort of like this like momentary fear. – P12, Non-Hodgkin Lymphoma 
For other participants, threat interpretations seemed almost ubiquitous and were described in terms 
of an immutable, conditioned connection between symptoms and cancer.  
You just associate everything with cancer, right? […]. Your mind always goes to like a 
negative, with everything, really. You always think the worst. – P11, AML 
For one participant, this deep conceptual connection between symptoms and cancer appeared to 
relate to a tendency to interpret ‘every’ new symptom as a potential threat. The explicit language 
use (bolded) exemplifies the extreme nature of the individual’s fear.  
I can’t stop the association of physical pain with being scared of cancer coming back. I feel 
like they’re tied together. Every time I like have a physical pain I’m like, ‘Oh f**k!’. Every 
time I feel short of breath I’m also like, ‘Oh f**k!’. – P7, Osteosarcoma 
Related to this portrayal of an immutable connection between symptoms and cancer is another 
participant’s description of being in a “constant state of vigilance ever since I was sick” (P4, brain 
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tumor). For some participants, this perceived need to be vigilant for possible symptoms of cancer 
or late effects was reflected in an active monitoring and scanning of their bodies. 
I'm just constantly looking out for [changes in breathing or heart rate]. – P24, Osteosarcoma 
For others, the need for vigilance resulted in a more behavioral response, particularly body 
checking behaviors. Whether described as cognitive or behavioural processes, the presented 
quotations reflect the felt need for participants to pay increased, sometimes excessive attention to 
their bodies and the somatic sensations therein.  
And so, for me, I’m always feeling for lumps and if something hurts in a really weird way I 
have to figure out why. – P9, Wilms Tumor 
Taken together, this first theme captures that participants described a felt need to be vigilant 
for post-cancer somatic sensations and to appraise these sensations as signals of bodily threat, 
presumably as part of a ‘better safe than sorry’ strategy to mitigate the possibility of missing a 
recurrence of their cancer or a future illness, and thus to promote future health. 
Theme 2: Playing detective with bodily signals 
As a result of being vigilant for and noticing new sensations, participants commonly 
described feeling a need to ‘play detective’ to try to determine whether or not their sensations 
indeed indicated a credible health threat. This second theme captures the cognitive and behavioral 
strategies that participants described using to guide their response to new and changing sensations. 
Participants described applying various cognitive heuristics to attempt to assess the threat 
level of their sensations. One such heuristic was the ‘duration’ rule: 
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If [pain]’s been happening for like a day and then it goes away then you know it’s okay. But if 
it’s like – it's like very bad and it's happening for like two or three days then I'll probably tell 
[the doctors]. – P25, ALL 
As evident in the quote above, several participants mentioned that they tried to assess how ‘bad’ a 
sensation was, and whether the severity of the sensation appeared to be excessive and whether it 
impacted their everyday life (i.e., a ‘severity of interference’ rule). 
So sometimes if I’m feeling like extra winded or like I'll have like a heart palpitation […], if 
I'm like tired and it's like I walked not that far and I'm like really tired I'm like ‘oh my – am I 
OK?’. – P24, Osteosarcoma 
Another commonly described cognitive heuristic was the ‘pattern rule’, particularly assessing 
whether the sensation went away and came back or intensified over time.  
If it’s just there and it disappears I’ll be like, ‘okay whatever.’ But if it’s like it's there and it’s 
not, it’s there and then not, I’m like, ‘okay what is this!’. – P10, Ewing Sarcoma 
For others, the quality of the sensation was considered central. The language use in the following 
quote (captured in bold) indicates that distinguishing sensations based on their quality was not an 
exact science, but represented more of a best guess.  
I've gotten to the point where I can kind of recognize like what a normal pain is versus like 
what is something that could be a little bit alarming, so that a normal pain would kind of be 
like an achiness, soreness. Something that would be more worrying would be kinda like a 
sharp pain or something. – P23, Osteosarcoma 
Participants described playing detective in their search for alternative causes of their symptoms.  
I had an idea that [the rash] was environmental cause like I probably needed to do laundry 
for my sheets like that was… the most logical explanation. P18, Hodgkin Lymphoma 
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For some, their language use (bolded) reflected that this search process was active and effortful. 
I try to figure out why something hurts. For example, if my legs hurt but I also like walked 
three miles the day before I’m like, ‘ok’. […] I do a lot of tracing back of what I’ve done and 
figure out why so that’s a lot of where my worry energy goes and figuring out why this is 
happening. – P7, Osteosarcoma 
If an alternative cause was not immediately apparent, participants described attempting behavioral 
experiments, including taking over the counter medication or pushing their body to test if their 
symptom translated into a functional decline.   
When you’re feeling faint or your energy levels are low and you can do something about it, 
you can like basically run it like a small test on yourself, you know let me just get up and… 
drive somewhere or walk somewhere or do something it’s almost like a test to myself like ‘okay 
like I’m able to do it, I’m just lazy, I don’t want to do it’. – P19, AML 
When faced with a symptom of concern, some participants described seeking reassurance from 
others, including parents. Others found comfort in the the recency of medical surveillance tests, 
indicating that symptom-related distress may follow a waxing-and-waning pattern in between 
follow-up visits.  
I started feeling a little more lethargic for whatever reason and I sorta like in the back of my 
head I was like, ‘oh wait like – no I just had a blood test and like it showed up everything was 
fine so like it’s not – it’s not the cancer, like that’s ridiculous’. – P12, Non-Hodgkin Lymphoma 
In addition to routine surveillance, participants sometimes described seeking additional 
reassurance from healthcare providers, which occasionally resulted in additional tests or scans. 
These data provide valuable insights into how symptom appraisal guides healthcare-seeking 
behaviors in this population. 
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If I didn’t get checked out it would just drive me crazy… I asked my mom about it and if it goes 
on for more than five days she’ll just be like, ‘alright we need to call the doctor cause you’re 
not going to stop psyching yourself out until you hear from them.’ – P8, Osteosarcoma  
Finally, while healthcare providers often provided a source of support and reassurance for new 
symptom-related concerns, it is important to acknowledge that some participants described their 
perceived need for symptom vigilance as stemming from the messages they received from the 
healthcare team. A clinical instruction to be vigilant for signs of recurrent or new disease, while 
well-intentioned, may inadvertently evoke symptom-related fears.  
I was pretty nervous just because it [the symptom] is something they always tell you about like 
‘make sure you’re checking for these symptoms’ and that was one they told me to look for so I 
got really worried. – P22, T-Cell ALL 
Taken together, the quotations in this theme highlight a wide range of strategies that 
participants described using to determine whether or not a sensation is threatening and how to 
respond to it. These strategies were influenced by medical surveillance and in some case included 
seeking additional surveillance tests, indicating the role of the healthcare team. Similar cognitive 
heuristics have been identified in quantitative work with adults who sought help for potential 
symptoms of cancer (Kummer et al, 2019). Overall, participants’ felt need to play detective with 
their bodily signals appeared effortful and sometimes energy-consuming, potentially indicating a 
mechanism through which the experience of somatic symptoms may increase fatigue in this 
population over time. The range and heterogeneity of the detective strategies that participants 
described also highlights a reality of cancer survivorship – that making sense of post-cancer 
sensations entails managing a great deal of uncertainty. This uncertainty is captured in our third 
and final theme.   
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Theme 3: Living with symptom-related uncertainty 
The final theme captures the uncertainty that participants described feeling around how to 
appraise and respond to somatic sensations after their cancer experience. This uncertainty was 
described as a recognition that post-cancer somatic symptoms are wily, unreliable, and influenced 
by psychological factors such as anxiety. In some ways, this final theme represents that a meta-
awareness of post-cancer symptoms as conscious signals of bodily threat, shaped by 
biopsychosocial factors rather than directly representing the state of body tissues.   
I’ll be kind of like, […] thinking about [the sensation], kinda testing it. […]. Maybe I’m 
pretending, maybe I’m not pretending, I just don't know. It's hard to trust yourself because you 
don't know what you're making up and you don't know what's real. – P24, Osteosarcoma  
Like for P24, some participants described perceiving symptoms as something their brains could 
be ‘making up’, rather than reflecting true tissue damage or illness.  
Cause like right now I have pain like right here. Right in my femur. It’s just like an ache. And 
I know I didn’t do anything to that, right? So, I just know it’s something like my body is doing. 
So that’s another thing where you’re like okay, could this be my – could this be a tumor or 
could this be this? And it’s just like a constant like, ‘oh! Is my brain doing this or is like actually 
something or did I hurt it?’ – P6, Osteosarcoma 
Although several sensations were described in such terms, pain was commonly identified as a 
sensation infused with uncertainty. One participant highlighted that pain, as compared to other 
sensations, is particularly difficult to interpret and to tie to a probable cause.  
Pain on the other hand is like, it’s a little more anxious feeling because, am I having pain 
because the body is so complicated? Or am I having pain cause of this or this or this? Or is it 
something that I don’t know about? – P19, AML 
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Several participants discussed self-enforced rationality as a strategy for coping with the inherently 
uncertain nature of post-cancer somatic sensations. P5 described some respite in considering that 
their symptom could be attributed to a less threatening health problem (i.e., the common cold). 
This suggests that some survivors may find it helpful to receive preemptive guidance towards 
alternative explanations for common, everyday symptoms from their survivorship care team (e.g., 
‘cancer survivors get colds, too’).  
It’s every time even in smaller things that thought is still there to a certain extent but I just – I 
feel like I have to look at things like realistically and be like, ‘oh do I have lung cancer or do 
I just have a little bit of a cold?’ – P5, Ewing Sarcoma 
Several participants stated that despite feeling anxious about a new symptom, they did not 
reach out to a doctor because they were not sure if their anxiety was warranted. While for some 
the decision to not contact the healthcare team appeared relatively straightforward, others 
described this decision-making process as a source of turmoil and conflict. This sense of conflict 
again seemed to align with a ‘better safe than sorry’ approach to interpret even likely-benign 
sensations as threatening, as exemplified by the following participant who claimed the following 
when asked if they ever consult their oncologist: 
I don’t think it’s that serious to tell her but at the same time I’m panicking because I think it’s 
serious. I don’t know. I’m drawing the line somewhere in my mind. I’m contradicting myself 
in a way that I –  now that I think back on it, it’s weird. I just thought it that it was not that 
serious but at the same time it’s just very real to me at the moment. Cause I thought there was 
an understanding somehow that I knew it was probably not – at the same time I’m very anxious. 
– P10, Ewing Sarcoma 
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Other particiapnts described instances where symptom-related concerns had sparked healthcare-
initiating behaviors and, in some cases, additional medical surveillance; this provides preliminary 
evidence indicating that the way childhood cancer survivors interpret symptoms can directly 
influence and increase healthcare utilization. Relatedly, some participants described that their 
symptom would disappear following reassurance, indicating that threat interpretations may serve 
to maintain the presence or salience of sensations themselves.  
I was really scared about [pain in my foot] but then we went and got it checked out and they 
said it was nothing and then like the pain went away. – P23, Osteosarcoma 
Understandably, while some participants described feeling relief in deciding that sensations were 
more likely ‘in their head’ than signaling cancer recurrence, the opposite appeared to be true for 
late effects. That is, some participants described relief in receiving evidence or validation that 
certain symptoms were a result of treatment rather than something they had ‘made up’. This 
indicates that different strategies may be more or less useful to promote coping depending on 
whether the symptom is interpreted as indicating a recurrence or a late effect of treatment.  
I think it’s really kinda like frustrating cause you’re just like, is it in my head? Am I inventing 
this feeling? […] I felt so, like affirmed when I think like some other patient who like had, 
chemo several years ago was like, ‘oh no it’s totally real, like even small things’ […]. Then I 
was like, ‘oh okay maybe I’m not just psycho and like there’s actually something going on 
here’ – P12, Non-Hodgkin Lymphoma 
Finally, although symptom-related uncertainty was salient for many of the participants, some 
described that their sense of uncertainty reduced across the survivorship trajectory, pointing 
towards a positive outlook. The building of greater certainty in symptom appraisal over time can 
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be understood within the extant literature indicating that survivorship represents a ‘new normal’ 
for those living beyond cancer (Appleton & Flynn, 2014; Trusson, Pilnick & Roy, 2016).  
I’m used to my new normal now or I’m used to, you know, the symptoms I’m feeling. I know 
how to deal with it. I know what’s normal and what is concerning. Cause that’s a huge thing 
that, you know, cancer survivors have to figure out. […] I’m very in tune with what’s normal 
for me. But learning what’s normal has been a process, right? – P4, Brain Tumor 
This third and final theme captures a critical issue that lies at the core of symptom appraisal 
that is relevant for those living beyond cancer and other chronic health conditions. Uncertainty 
underlies the need to make sense of all changes in bodily state, yet it is particularly salient in the 
context of an ambiguous and life-changing health threat. In cancer survivorship, as in other 
diseases with a relapsing-remitting pattern (e.g., irritable bowel disease, multiple sclerosis), the 
individual must make sense of changing somatic sensations within the broader context of living in 
a state of health purgatory, ever betwixt and between ‘healthy’ and ‘sick’ (Rees, 2018).  
DISCUSSION 
 Making sense of somatic sensation is a critical challenge when navigating a current or 
possible illness. Using a hybrid deductive-inductive thematic analysis with in-depth interview data, 
we generated novel insights into the process and influence of somatic sensation perception within 
a salient context of health-related uncertainty: childhood cancer survivorship. Our analysis yielded 
three core themes. These themes revealed that participants described commonly interpreting 
somatic sensations as indicating cancer recurrence or new illness (theme 1: symptoms as signals 
of bodily threat) and a felt need to monitor and assess changing somatic sensations during 
survivorship (theme 2: playing detective with bodily signals). These first two themes can be 
understood within participants’ broader recognition that post-cancer symptoms are wily, difficult 
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to interpret, and often influenced by psychological factors such as anxiety (theme 3: living with 
symptom-related uncertainty). Across the three themes, we identified how participants’ symptom 
appraisals were influenced by clinical practice (e.g., clinician-directed self-monitoring) and 
subsequently influenced healthcare utilization (e.g., contacting the oncology team and seeking 
additional tests). Thus, our findings indicate that the way individuals interpret and respond to 
somatic sensations within an uncertain health context is interrelated with healthcare provision. 
 Our findings build on previous studies in cancer survivor populations. In particular, 
quantitative studies have indicated that somatic sensations such as pain and fatigue are common 
after cancer (Pachman et al., 2012) and are associated with higher fear of cancer recurrence 
(Kelada et al., 2019; Simard et al., 2013) and reduced quality of life (Huang et al., 2013). Our 
qualitative data indicates one reason why post-cancer symptomatology may exacerbate 
psychological distress – because it triggers fear of cancer recurrence or treatment sequelae. These 
findings replicate another recent qualitative study with childhood cancer survivors (Tutelman et 
al., 2019) and indicate the need for validated measures that capture individual differences in the 
extent to which survivors perceive somatic sensations as indicative of bodily threat. Qualitative 
data are well suited to guide new new measurement development, particularly by revealing patient-
centric language than can be directly translated into measurement items. Studies that capture the 
dynamic nature of symptom appraisal and health-related fears over time, including Ecological 
Momentary Assessments (EMA), will also be helpful to expose the symptom-distress relationship.  
Our findings also build on the well-established study of cancer symptom clusters (Fan et 
al., 2007). Individuals living with and beyond cancer can experience an array of co-occurring 
symptoms (e.g., pain, fatigue, sleep disturbance), and the targeting of these clusters through 
intervention is yielding promising results for reducing symptom burden and improving quality of 
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life. Tentatively, our findings suggest that a general tendency to interpret somatic sensations as 
signals of bodily threat could act as a mechanism maintaining symptom co-occurrence in this 
population through a process of increased body vigilance, perceived need for protection, and 
somatic windup; this hypothesis warrants empirical investigation.  
 Our findings should also be situated within the broader study of uncertainty and risk 
perception in healthcare. Uncertainty in illness has been a central feature of health psychology 
research for several decades, situated within core theoretical frameworks (Mishel, 1988). Illness-
related uncertainty and appraisals have emerged as key factors associated with child and parent 
adjustment in childhood cancer (Fortier et al., 2012; Mullins et al., 2016; Szulczewski et al., 2017). 
In both child and adult survivors of cancer, this uncertainty appears to be a significant corollary of 
both somatic symptoms and quality of life (Cahill et al., 2012; Fortier et al., 2012). In a qualitative 
study, Rees (Rees, 2018) described adult cancer survivors’ experiences of uncertainty as a state of 
‘embodied risk’, thereby illuminating fear of cancer recurrence as an embodied experience and 
again providing credence for the fruitful study of symptom appraisal as a trigger of fear of 
recurrence. Beyond oncology, perceived uncertainty is shown to have strong relationships with 
somatic symptoms and quality of life in those undergoing ‘watchful waiting’ for diseases such as 
chronic hepatitis C (Bailey et al., 2009). Since the advent of precision medicine and genetic testing, 
there are emerging necessities for understanding how symptoms are perceived and responded to 
as signals of bodily threat within this new and uncertain context. For example, how does knowing 
one has an inherited vulnerability for disease influence one’s mindset about their body, their 
interpretation of ambiguous somatic sensations, and resultant healthcare behaviours? Helping 
individuals cope with symptom-related uncertainty may be an important addition to genetic 
counselling. Given our findings that participants often anchored their symptom interpretations on 
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their initial diagnosis and treatment, it will be helpful to use similar qualitative methods to 
understand how individuals appraise symptoms without a personal experience on which to anchor 
those appraisals.  
 Finally, our findings have implications for clinical practice. Several participants identified 
that the healthcare team played a role in their symptom monitoring practices, whether via explicit 
instruction to engage in symptom self-monitoring or via enquiring about symptoms at surveillance 
visits and thus implicitly (and likely inadvertently) triggering a perceived need to be vigilant for 
these symptoms. It will be helpful to further explore, through qualitative and quantitative studies, 
how and to what extent the healthcare team has an influence on symptom appraisals through how 
they counsel patients, whether they could decrease distress by discussing the likelihood of various 
symptoms heralding recurrence, and whether certain approaches by healthcare providers 
encourage or discourage contact from patients about symptoms of concern. Normalizing symptom-
related concerns as a typical post-cancer experience could usefully be offered as anticipatory 
guidance to individuals finishing cancer treatment (Heathcote et al., 2018). Relatedly, participant 
experiences particularly captured in the third theme (‘living with symptom-related uncertainty’) 
point towards the broader need to validate symptom-related concerns during survivorship. While 
the healthcare team will be one source for such validation, some participants described relief upon 
hearing that peers who had also completed childhood cancer treatment experienced similar 
symptom-related concerns. Thus, our findings point towards the valuing of both medical and 
experiential knowledge in offering validation for post-cancer symptom experiences.  
 This study has limitations, pointing towards future research directions. First, we over-
sampled certain diagnostic groups. Future studies would benefit from targeting other groups (e.g., 
central nervous system tumors) to understand their unique experiences and ensure that future 
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evidence-based interventions can meet their needs. Second, although our sample was more 
ethnically diverse than previous studies (Tutelman et al., 2019), certain minority groups, 
particularly African Americans, were underrepresented. Finally, while our theory-driven approach 
afforded a unique insight into theory-relevant processes, we have likely missed insights that would 
have stemmed from an entirely inductive approach. For example, as the CTI model is largely 
intrapersonal, our analyses did not reveal a significant role of parents that was observed in a 
previous study (Tutelman et al., 2019).  
Living with risk for a new or recurrent health condition is a context permeated by 
uncertainty. Here we present an in-depth exploration of one facet of this uncertainty, specifically 
that of symptom appraisal. Our findings are relevant not only for understanding cancer 
survivorship but also symptom perception within any uncertain health context. In particular, our 
theory- and person-centered analysis yielded findings that can help move our understanding of 
symptom perception from a biomedical perspective (symptoms as markers of bodily state) towards 
a functional-motivational perspective (symptoms as signals of bodily threat). They may also help 
move us from viewing persistent somatic symptoms as an abnormal psychosomatic manifestation 
of distress, towards a normal response to a credible health threat (Heathcote, 2019). 
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